drugset / Trial / NCT01591070

Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

NCT01591070 ↗

Phase 4 Completed 104 enrolled Pusan National University Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether proactive use of 0.1% tacrolimus ointment once or twice weekly can keep adult facial SD in remission and reduce the incidence of exacerbation.

Timeline

Start
2010-11
Primary completion
2011-05
Completion
2011-05

Outcome

Met primary endpoint

paper In conclusion, twice-weekly treatment with 0.1% tacrolimus ointment had superior effects in keeping facial seborrhoeic dermatitis in remission. PMID 23388687 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.1 % Topical

Indications